Nuformix (LON:NFX) Trading 4.2% Higher – Time to Buy?

Nuformix plc (LON:NFX) shot up 4.2% during mid-day trading on Wednesday . The company traded as high as GBX 0.26 and last traded at GBX 0.25. 17,557,332 shares were traded during trading, a decline of 54% from the average session volume of 38,040,898 shares. The stock had previously closed at GBX 0.24.

Nuformix Stock Up 13.8%

The business’s 50-day simple moving average is GBX 0.26 and its two-hundred day simple moving average is GBX 0.22. The firm has a market cap of £5.76 million, a price-to-earnings ratio of -6.95 and a beta of 1.22.

Nuformix (LON:NFX) last issued its quarterly earnings data on Tuesday, January 27th. The company reported GBX (0.04) EPS for the quarter.

About Nuformix

Nuformix plc operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom. It offers NXP001, which has completed Phase 1 for use in oncology supportive care. The company is also developing NXP004, a novel form of Olaparib, which is in the IP generation phase for treating oncology; and NXP002 that is in pre-clinical stage for the treatment of idiopathic pulmonary fibrosis. It also has an option agreement with Oxilio Ltd. for NXP001 for oncology indications.